Portage Biotech Inc. (PRTG)
NASDAQ: PRTG · Real-Time Price · USD
5.61
+0.19 (3.51%)
Aug 4, 2025, 2:26 PM - Market open
Portage Biotech Balance Sheet
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Cash & Equivalents | 1.67 | 5.03 | 10.55 | 23.35 | 2.77 | Upgrade |
Cash & Short-Term Investments | 1.67 | 5.03 | 10.55 | 23.35 | 2.77 | Upgrade |
Cash Growth | -66.79% | -52.32% | -54.84% | 743.03% | -13.98% | Upgrade |
Other Receivables | 0.01 | 0.04 | 0.24 | 0.21 | 0.68 | Upgrade |
Receivables | 0.01 | 0.04 | 0.68 | 0.21 | 0.68 | Upgrade |
Prepaid Expenses | 0.48 | 2.56 | 2.33 | 1.13 | 1.49 | Upgrade |
Other Current Assets | 0.07 | 0.06 | 0.12 | 0.14 | - | Upgrade |
Total Current Assets | 2.23 | 7.7 | 13.68 | 24.83 | 4.95 | Upgrade |
Property, Plant & Equipment | - | 0.04 | - | - | - | Upgrade |
Long-Term Investments | - | - | 2.89 | 9.08 | 9.14 | Upgrade |
Goodwill | - | - | - | 43.32 | 43.32 | Upgrade |
Long-Term Deferred Charges | - | - | 82.52 | 117.39 | 117.39 | Upgrade |
Other Long-Term Assets | - | 0.05 | 0.04 | 0.04 | 0.06 | Upgrade |
Total Assets | 2.23 | 7.78 | 99.13 | 194.66 | 174.86 | Upgrade |
Accounts Payable | 0.43 | 0.48 | 0.27 | 0.19 | 0.11 | Upgrade |
Accrued Expenses | 0.66 | 2.31 | 1.56 | 0.52 | 1.79 | Upgrade |
Current Portion of Long-Term Debt | - | - | - | - | 0.15 | Upgrade |
Current Portion of Leases | - | 0.04 | - | - | - | Upgrade |
Other Current Liabilities | 0.01 | 0.05 | 0.03 | 0.07 | 1.15 | Upgrade |
Total Current Liabilities | 1.1 | 2.88 | 1.87 | 0.78 | 3.21 | Upgrade |
Long-Term Leases | - | 0.01 | - | - | - | Upgrade |
Long-Term Deferred Tax Liabilities | - | - | 10.56 | 28.45 | 24.05 | Upgrade |
Other Long-Term Liabilities | 1.95 | 1.56 | 11.31 | - | - | Upgrade |
Total Liabilities | 3.05 | 4.45 | 23.73 | 29.23 | 27.26 | Upgrade |
Common Stock | 221.8 | 219.5 | 218.78 | 158.32 | 130.65 | Upgrade |
Retained Earnings | -245.45 | -239.32 | -159.62 | -55.01 | -38.14 | Upgrade |
Comprehensive Income & Other | 23.53 | 23.84 | 16.88 | 17.89 | 8.94 | Upgrade |
Total Common Equity | -0.12 | 4.02 | 76.05 | 121.21 | 101.45 | Upgrade |
Minority Interest | -0.7 | -0.69 | -0.65 | 44.23 | 46.15 | Upgrade |
Shareholders' Equity | -0.83 | 3.33 | 75.4 | 165.43 | 147.6 | Upgrade |
Total Liabilities & Equity | 2.23 | 7.78 | 99.13 | 194.66 | 174.86 | Upgrade |
Total Debt | - | 0.05 | - | - | 0.15 | Upgrade |
Net Cash (Debt) | 1.67 | 4.98 | 10.55 | 23.35 | 2.62 | Upgrade |
Net Cash Growth | -66.47% | -52.76% | -54.84% | 791.30% | - | Upgrade |
Net Cash Per Share | 1.41 | 5.15 | 13.08 | 35.76 | 4.47 | Upgrade |
Filing Date Shares Outstanding | 2.28 | 1.05 | 0.89 | 0.85 | 0.67 | Upgrade |
Total Common Shares Outstanding | 1.65 | 0.99 | 0.88 | 0.67 | 0.6 | Upgrade |
Working Capital | 1.13 | 4.82 | 11.81 | 24.05 | 1.74 | Upgrade |
Book Value Per Share | -0.07 | 4.07 | 86.39 | 181.59 | 167.91 | Upgrade |
Tangible Book Value | -0.12 | 4.02 | 76.05 | 77.88 | 58.13 | Upgrade |
Tangible Book Value Per Share | -0.07 | 4.07 | 86.39 | 116.68 | 96.21 | Upgrade |
Updated Nov 26, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.